Document Detail


Detection of experimental hepatic tumors using long circulating superparamagnetic particles.
MedLine Citation:
PMID:  11176257     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE AND OBJECTIVES: To evaluate the potential of an iron oxide-based MR contrast agent for the detection and delineation of experimental liver tumors during the early vascular phase of the compound. METHODS: Superparamagnetic blood pool agent (SBPA) was administered intravenously to rabbits bearing VX2 tumors. Images were acquired before the injection, immediately after, and 1 or 3 weeks later. The variations of signal intensity were measured in the tumors and in several tissues for various T1-weighted spin-echo, T2-weighted fast spin-echo, and T2-weighted gradient-recalled-echo sequences. RESULTS: Fourteen and 12 of the 16 tumors were detected immediately after SBPA injection using, respectively, the T2-weighted fast spin-echo and T2-weighted gradient-recalled-echo sequences. A significant decrease in signal intensity was observed in well-perfused organs, and blood signal was abolished even at the lowest injected dose and using a T1-weighted sequence. In the late phase, the loss in signal intensity of the liver was even more pronounced. CONCLUSION: The dominant T2 effect of SBPA induces an increase in the tumor-to-liver and tumor-to-blood contrast during the vascular phase, improving the detection of the tumors and allowing the distinction between small lesions and vessels through plane. This effect on the liver signal persists for several days because of the incorporation of SBPA in the reticuloendothelial system.
Authors:
Y Sayegh; S Pochon; J P Vallée; M Becker; F Lazeyras; H Tournier; R Hyacinthe; X Fouillet; F Terrier
Related Documents :
15122677 - Comparison of bold contrast and gd-dtpa dynamic contrast-enhanced imaging in rat prosta...
2004297 - Integrated magnetic resonance imaging and phosphorus spectroscopy of soft tissue tumors.
8584827 - Early effects of gamma knife surgery on malignant and benign intracranial tumors.
14599607 - Marked variability of melphalan plasma drug levels during regional hyperthermic isolate...
181127 - Signet-ring stromal tumor of ovary. histochemical, light, and electron microscopic study.
14667507 - The t(1;3) breakpoint-spanning genes lsamp and nore1 are involved in clear cell renal c...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Investigative radiology     Volume:  36     ISSN:  0020-9996     ISO Abbreviation:  Invest Radiol     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-01-23     Completed Date:  2001-06-07     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0045377     Medline TA:  Invest Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  15-21     Citation Subset:  IM    
Affiliation:
Départment de Radiologie, H pital Universitaire de Genéve, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Contrast Media*
Ferric Compounds / diagnostic use*
Ferrosoferric Oxide
Liver Neoplasms / pathology*
Magnetic Resonance Imaging
Neoplasms, Experimental / pathology*
Rabbits
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Ferric Compounds; 0/superparamagnetic blood pool agent; 1317-61-9/Ferrosoferric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatocyte targeting with Gd-EOB-DTPA: potential application for gene therapy.
Next Document:  Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blin...